Study Title
Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients With Muscle Invasive Bladder Cancer (EFFORT-MIBC): A Phase II Prospective Trial
Study Details
Description:
Evaluate the impact of 18F-FDG-PET-CT on the staging of patients with muscle invasive bladder cancer. Based on the results of 2 18F-FDG-PET-CT's patients are stratified in non-metastatic, oligometastatic and polymetastatic bladder cancer patients and the treatment is adapted accordingly to improve overall survival.
Sponsor:
University Hospital, GhentContacts:
Valerie Fonteyne, MD; PhD (Principal Investigator)valerie.fonteyne@uzgent.be
+3293323015
Flor Verghote, MDvalerie.fonteyne@uzgent.be
Government Study Link:
NCT04724928 - Click here to see study onClinicalTrials.gov